Published by Iain Gilbert on 2nd December 2024
(Sharecast News) - Analysts at Berenberg lowered their target price on drugmaker GSK from £18.20 to £16.00 on Monday after hosting chief financial officer Julie Brown at its 2024 Pharma CFO series.
URL: http://www.digitallook.com/dl/news/story/34725844/...